Euro Medchem Conferences , Euro Medchem 2024, CADD 2024 Events , Euro Medchem and CADD, CADD Conferences , Euro Medchem Meetings , Euro Medchem and CADD, Euro Medchem and CADD Congress 2024 , Euro Medchem Symposiums , Euro Medchem Convention

Renowned Speakers

Anna-Lena Merten

Friedrich-Alexander-University Erlangen-Nuremberg, Germany

Michael Chorny

University of Pennsylvania USA

MINHONG CHOA

Yonsei University South Korea

Wafa T. Al-Jamal

University of East Anglia UK

Dr Declan Chibueze Onyechege

Researcher On Health Economics, Economic Development And Economic Growth

Ms. Inna Bulygina

National University of Science and Technology "MISiS", Russian Federation Russia

Pedro MorouÃ§o

Polytechnic of Leiria Portugal

Victor Allisson da Silva

Federal University of ABC Brazil

Recommended Global Pharmaceutical Sciences Webinars & Conferences

Europe & UK

Clinical Trials Congress-2025, France Future Pharma 2025, Netherlands Cardiovascular-2025, France Biotech-2025, France PHARMACEUTICAL SCIENCES 2025, France

Asia Pacific & Middle East

Canada

PHARMA MEDICINAL CHEMISTRY 2025, Canada Pharmatech 2025, Canada PHARMA EDUCATION 2025, Canada Drug Delivery 2025, Canada Pharmaceutica-2025, Canada

Euro MedChem and CADD 2024

About Conference

It is our great pleasure and honour to invite you to the 3^rdWorld conference on Medicinal Chemistry and Computer Aided Drug Design. Which is to be held on Amsterdam, Netherlands during Spetember 18-19, 2024 | Euro Med Chem and CADD 2024 Highlighting the theme “Innovations in Medicinal Chemistry and Computational Drug Discovery: Advancing Healthcare for a Sustainable Future” provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking. This conference provides an excellent opportunity to discuss the latest developments within the field.

As a section of initiative aimed to share best approaches in medicinal chemistry the international conference is preparing the series of interesting topics under medicinal chemistry (i.e., biochemistry, molecular biology, pharmacognosy, and toxicology) and their suitable uses in the treatment of disease.

Medicinal chemistry conference serves as a global platform to discuss and learn about medicinal chemistry, organic molecules used in medicinal chemistry, Drug design and drug development, bioavailability, pharmacodynamics, pharmacokinetics, organic chemistry, pharmaceutical industry, Evolution of Organic Chemistry and Medicinal Chemistry in Pharma, Organic and Medicinal Chemistry Technologies for Drug Discovery, Drug effects , Medicinal Chemistry in Drug Discovery, Market Dynamics, Conclusions and Future Trends, Medicinal Plants.

In the view of this theme, the conference intent to provide a forum for international researchers from various areas of chemistry, pharmacy, Medicinal Chemistry and Drug Design by providing a platform for critical analysis of new designing, and to share newest cutting-edge research findings and results about all aspects of medicinal chemistry. The current meeting of chemistry conferences will be a multinational gathering and present major areas such as Medicinal Chemistry, Pharmaceutical Sciences, Drug Design and Drug Development, Organic Chemistry , pharmacology and overall applications.

Target Audience:

Experts within the development of Medicinal chemistry
Laboratory Chemists
Chemical Scientists performing on Medicinal Chemistry
Professors in Pharmaceutical sciences and Chemistry
Junior research scientists performing on Medicinal chemistry
Post-doctoral and Researchers in Pharmaceutical sciences and Chemistry
Post Graduates and Graduates in Pharmaceutical sciences and Chemistry
Associate and Assistant Professors in Pharmaceutical sciences and Chemistry

Young Scientists Benfits:

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners.Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development Award should motivate participants to strive to understand their full potential which could successively be beneficial to the sector as whole

Sessions & Tracks

Track 01: Analytical Chemistry

Analytical ChemistryIn the pharmaceutical industry, analytical chemists are entangled within the entire process, from drug discovery to market, studying the physical or chemical properties of drug substances and formulations to defining the quality and stability of drug products to make sure the safety of the drug. The review highlights a diversity of analytical techniques like titrimetrie, chromatographic, spectroscopic, electrophoretic, and electrochemical and their equivalent methods that are applied within the analysis of pharmaceutical.

Track 02: Organic Chemistry and Inorganic Chemistry

Organic chemistry plays a crucial role in the pharmaceutical industry whereby information of organic compounds is used to enlighten research and further the discovery, research and development of new medicines. Organic molecules perform significant functions in nature, drug, and technology. It plays as the engine for understanding structure and reactivity. The role played by organic chemist in pharmaceutical industry remains to be one of the main drivers in the drug discovery process. Metal ions play vital role in biological processes and the field of comprehension concerned with the application of inorganic chemistry. some of the inorganic compounds used as drugs and diagnostic agent. Lithium drugs such as lithium carbonate Li2C03! are used for the treatment of manic-depressive disorders. The mode of action of cisplatin is due to release of chloride ions on crossing cell membrane.

Track 03: Applied Medicinal Chemistry

Applied Medicinal Chemistry includes synthetic chemistry and aspects of natural products and computational chemistry in near combination with chemical biology, enzymology and structural biology, together aiming at the invention and development of latest therapeutic agents.

Track 04: Pharmaceuticals and Nutraceuticals

Pharmaceutical supplements have high concentrations of small group of vitamins and minerals, while nutraceuticals have all the advantages of natural foods. The term “nutraceutical” is employed to explain these medicinally or nutritionally functional foods. Nutraceuticals have the advantage over medicines since they avoid side effects and naturally dietary supplements, etc. on the idea of their natural source, chemical grouping, and categories, fall under three key terms, nutrients, herbals, dietary supplements, dietary fiber, A nutraceutical are often a nutrient-rich food, medicinally active food, or a selected component of a specific food, consistent with medicine net. for examples pharmaceutical supplements have high concentrations of one or small group of vitamins and minerals, while nutraceuticals have all the advantages of natural foods include garlic, omega 3 (found in fish), soybeans, ginger, minerals, vitamins, dietary fiber, hydrolyzed proteins, fortified foods, enriched foods, then far more. We are all advocates for all-natural nutrition, but thanks to the legal claim that only drugs can cure, prevent or mitigate. Nutraceuticals can't be recommended by doctors when someone is affected by illness.

Tracks 05: Mass Spectrometer

Mass spectrometry (MS) is an analytical technique that's used to measure the mass-to-charge ratio of ions A mass spectrum is a plot of the ion signal as a function of the mass-to-charge ratio. These spectra are used to determine the basic or isotopic signature of a sample, the masses of particles and of molecules, and to elucidate the chemical identity or structure of molecules and other chemical compounds. There are four stages in a mass spectrometer which we need to study, these are – ionization, acceleration, deflection, and detection. Mass spectrometry is employed in many diverse fields and is applied to pure samples also as complex mixtures.

Tracks 06: Chromatography & Separation techniques

Chromatography is a procedure for separating components of a mixture. The various components of the mixture travel through the stationary phase at different speeds, causing them to separate from one another. By using chromatographic technique, we can Precise separation, analyses, and purification. there are two phases in chromatography 1) Stationary phase and 2 mobile phase. They are 5 different types of chromatographic techniques 1. Column Chromatography 2. Paper Chromatography 3. Thin Layer Chromatography 4. Gas-Liquid Chromatography (GLC) or Simply Gas Chromatography (GC) 5. High Performance Liquid Chromatography

Track 07: Bio-Organic Chemistry

Bioorganic chemistry is a widely growing science that combines organic chemistry and biochemistry. It’s the branch of life science that deals with the study of biological processes using chemical methods. It represents the meeting of ,biochemistry in its broadest sense, with organic chemistry in an effort to explain and control complex biological systems at the molecular level Protein and enzyme function are samples of these processes. sometimes biochemistry is employed interchangeably for bioorganic chemistry (i.e., bioorganic chemistry aims at understanding biological aspects using chemistry). Bioorganic chemistry attempts to expand organic-chemical research (structure, synthesis, and kinetics) towards biology. Bioorganic chemistry seeks not only to know and control cellular and biochemical processes, but also mimic them.

Tracks 08: Environmental catalysis and green chemistry

Environmental catalysis refers to catalytic technologies for reducing emission of environmentally unacceptable compounds. Finally, the reduction of the environmental impact within the use or disposal of catalysts must even be cited as a part of the objectives of environmental catalysis. Heterogeneous catalysts are efficiently used to reduce nitrogen oxides (NOx) emissions from stationary sources (power plants, boiler), to process oil in obtaining cleaner fuels having low Sulphur and nitrogen content, to destroy waste, pesticides, dioxane and furane, to regulate the Volatile Organic Compounds (VOCs) Green chemistry is that the design of chemical products and processes that reduce or eliminate the utilization or generation of hazardous substances. Green chemistry applies across the life cycle of a chemical product, including its design, manufacture, use, and ultimate disposal Plants and animals suffer less harm from toxic chemicals within the environment. Lower potential for global warming, ozone depletion, and smog formation. Less chemical disruption of ecosystems. Less use of landfills, especially hazardous waste landfills

Track 09: NMR role in rational drug design

NMR Spectroscopy plays a crucial role in the discovery of drug and its development process. NMR screening experiments are very effective and versatile in discovering high-affinity ligands for biologically relevant macromolecules, elucidating ligand-binding sites, identifying small molecules with wide ranges of binding affinity and thus proving to be a valuable and robust tool in the structure-based drug design.it is very efficient in drug discovery and development as it can shed light on the molecular structure of the biomolecules, explicate and verify the structure of the drugs, and provide structural information on the interaction of the biomolecules (target) with small molecule compounds. thus, NMR spectroscopy proves to be an excellent tool in pharmaceutical research.

Track 10: Genotoxicity

In genetics, genotoxicity explains the property of chemical agents that destruct the genetic information inside a cell triggering mutations, which may lead to cancer. While genotoxicity is usually confused with mutagenicity, all mutagens are genotoxic, but not all genotoxic substances are mutagenic. The differentiation can have direct or indirect effects on the DNA. the orientation of mutations, misjudged event activation, and direct DNA damage leading to mutations Cells prevent expression of the genotoxic mutation by either DNA repair or apoptosis; however, the damage might not always be determined leading to mutagenesis.

Track 11: Ethno pharmacy

Ethnopharmacy is the study of how various medicines are viewed and put to use in a society. Although ethnopharmacy focus on traditional or folk medicines used in the society, it also looks at more modern pharmaceutical uses. It is the study of origin of pharmaceuticals, whether they are from naturally happening or man-made elements. They also study how pharmaceuticals are directed to people in the society and how productive the pharmaceuticals are at contending various medical conditions.

Track 12: Molecular and Cellular pharmacology

Molecular pharmacology deals with the understanding of the molecular basis for the actions of drugs and the characteristics of interactions between the drug molecules and those of the substrates of drug action in the cell. Whereas cellular pharmacology deals with the study of drug effects on various cell functions. Molecular pharmacology includes molecular signalling, chemical biology, structure of drug-receptor complex, system analysis of drug action and drug transport.

Track 13: Phytochemistry and Phytopharmaceuticals

Phytochemistry is the study of phytochemicals, which are chemicals obtained from plants. Phyto chemists strive to elucidate the structures of the massive number of secondary metabolites found in plants, the functions of those compounds in human and plant biology, and therefore the biosynthesis of those compounds. Plants synthesize phytochemicals for various reasons, as well as to guard themselves against the insect attacks and plant diseases. The compounds found in plants are of the various kinds, but maximum are repeatedly grouped into four major biosynthetic classes: alkaloids, phenylpropanoids, polyketides, and terpenoids. Phytochemical studies focused in the direction of human (i.e., drug discovery) use may drop into the discipline of pharmacognosy.it even have significance to the sector of plant physiology. Phytopharmaceutical drug is defined as refined and consonant fraction with defined minimum four bio-active or phytochemical compounds (qualitatively and quantitatively assessed) of an extract of a medicinal plant or its part, for internal or external use of human beings or animals for diagnosis, treatment.

Tracks 14: chemical synthesis and catalysis

In chemistry, chemical synthesis (or combination) is that the artificial execution of useful chemical reactions to get one or several products. this happens by physical and chemical manipulations usually involving one or more reactions. In modern laboratory uses, the method is reproducible and reliable. A chemical synthesis involves one or more compounds (known as reagents or reactant) which will undergo a change when subjected to certain conditions. Various reaction types are often applied to formulate a desired product. these needs mixing the compounds in a reaction vessel, like a chemical reactor or an easy round-bottom flask. Many reactions require some sort of work-up or purification procedure to isolate the ultimate product. Catalysis is a term describing a process during which the rate and/or the result of the reaction is influenced by the presence of a substance (the catalyst) that's not consumed during the reaction which is subsequently removed if it's not to constitute as an impurity within the final product.

Track 15: Pharmacokinetics

Pharmacokinetics which is abbreviated as PK, is a branch of pharmacology dedicated to figure out the fate of medicine administered to a living organism. It is defined as study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in a private patient. it can be used to study the onset, duration, and intensity of the effect of a drug.

Track 16: Pharmacogenomics

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combination of pharmacology and genomics. It analyzes how the genetic makeup of individual affects their response to drugs. pharmacogenomics is typically used interchangeably with pharmacogenetics. pharmacogenetics focuses on single drug-gene interactions, whereas pharmacogenomics incorporates genomics and epigenetics while handling the results of multiple genes on drug response. Pharmacogenomics aims to develop rational means to optimize drug therapy, with regard to the patients' genotype, to form sure maximum efficiency with minimal adverse effects.

Track 17: Pharmacodynamics

Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body and involves receptor binding (including receptor sensitivity), post receptor effects, and chemical interactions. the results can include those manifested within animals, microorganisms, or combinations of organisms.it is sometimes described as what a drug does to the body Pharmacodynamics. pharmacodynamics is a branch in pharmacology.

Track 18: Pharmacognosy

Pharmacognosy is defined as the study of plants or other natural sources as a possible source of drugs. pharmacognosy is also considered as "the study of the biochemical, physical, chemical, and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin as the design for brand spanking new drugs from natural sources". In other terms the word pharmacognosy is simply understand as the “knowledge of drugs”. it is also considered as the " study of natural product molecules such as secondary metabolites which are useful for their ecological, medicinal, gustatory, or other functional properties." Other definitions are more about, drawing on a broad spectrum of biological subjects, which includes botany, ethnobotany, marine biology, microbiology, herbal medicine, chemistry, biotechnology, phytochemistry, pharmacology, pharmaceutics, clinical pharmacy and pharmacy practice. Pharmacognosy is used by pharmaceutical companies to screen, describe and produce new drugs for the treatment of human disease. Often, naturally occurring drugs cannot be mass-produced, so they must be studied in order to develop synthetic biosimilars.

Track 19: Chemogenomic

Chemo genomics, or chemical genomics, is the systematic High-throughput screening (HTS) of targeted chemical libraries of small molecules against individual biological target families (e.g., nuclear receptors, kinases, proteases, etc.) with the ultimate goal of discovering novel drugs and drug targets. Typically, a few members of a target library have been well characterized where both the function has been determined and compounds that modulate the function of those targets (ligands in the case of receptor or inhibitor of enzymes) have been identified. Other members of the target family may have unknown function with no known ligands and hence are classified as adaptor orphan. Chemo genomics draw together the most powerful concepts in modern chemistry and biology, linking combinatorial chemistry with genomics proteomics.

Track 20: Bio isosteres

In medicinal chemistry, bio isosteres are chemical substituents or groups with similar physical or chemical properties which produce largely similar biological properties to alternative chemical compound. In drug design, the purpose of exchanging one bio isostere for another is to increase the desired biological or physical properties of a compound without making substantial deviations in chemical structure. The main research of this term and its techniques are related to pharmaceutical sciences. Bio isosterism is used to condense toxicity, change bioavailability, or alter the activity of the lead compound, and may modify the metabolism of the lead.

Track 21: Drug Metabolism

Drug metabolism is the metabolic cessation of drugs by living organisms, usually through specialized enzymatic systems. More usually, xenobiotic metabolism (from the Greek xenon "stranger" and biotic "related to living beings") is that the set of metabolic pathways that alter the chemical structure of xenobiotics, which are compounds external to an organism's standard biochemistry, like any drug or poison. These pathways are a kind biotransformation existing together with the major groups of organisms and are measured to be an ancient origin. These reactions often act to detoxify poisonous compounds (although in some cases the intercedes in xenobiotic metabolism can themselves toxic effects). The study of drug metabolism is known as pharmacokinetics. it's divided into three phases. In phase 1, enzymes like cytochrome P450 oxidases introduce reactive or polar group into xenobiotics. These compounds then conjugated to polar compounds in clinical test phase II. These reactions are catalysed by transferase enzymes like glutathione S-transferases. And in last phase these conjugated xenobiotics could even be further processed, before being recognized by efflux transporters and pumped out of cells.

Track 22: Antibiotics

Antibiotics are medicines that fight against bacterial infections in people and animals. Antibiotics are considered as anti-bacterial. It is the utmost important form of antibacterial agent fighting against bacterial infections, and antibiotic medications are extensively used in the treatment and inhibition of such infections. A restricted number of antibiotics also hold antiprotozoal activity. The most commonly used antibiotics are penicillin, ampicillin, cephalexin, ciprofloxacin, azithromycin, erythromycin etc. Antibiotics are often used to treat protozoan infections. (Metronidazole is effective against a sum of parasitic diseases). Antibiotics may either kill or inhibit the growth of bacteria.

Track 23: Drug development

Drug development is the method of carrying a new drug molecule into clinical practice. In its widest description this includes all steps from the basic research procedure of finding a suitable molecular target to supporting the marketable launch of the drug. It contains four different stages in which each stage has its own significance in stage 1 discovery and development takes place in preclinical research, inn stage3 clinical development in stage 4 FDA Review. The eventual goal of drug development is to bring a novel compound with verified therapeutic effect to the market.

Track 24: Biological drugs in auto immune diseases

Biologic therapies rheumatologic diseases, which are targeted at molecules tangled in the mechanisms of immune system, offer a substitute to the present treatment approaches of disease-modifying anti-rheumatic drugs and immunosuppressive medications. Biologics, or biological response modifiers, might be used to treat autoimmune diseases, including many types arthritis, such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Biologics work by disturbing the inflammation process that leads to joint pain and destruction. Non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, disease-modifying antirheumatic drugs (DMARDs) are conservatively used in dealing with autoimmune inflammatory diseases.

Track25: Auto- immune drugs

Immunosuppressant drugs are used to treat autoimmune diseases. Through an autoimmune disease, the immune system attacks one’s own body tissues. Because immunosuppressant drugs deteriorate the immune system, they overturn this reaction. This helps diminish the influence of the autoimmune disease on the body. The top three auto immune drugs are Xelijanz (tofacitinib), Olumiant (baricitinib), Cosentyx (seukinumab).

Track 26: Medicinal Chemistry for drug discovery

Medicinal chemists play an important role in driving the drug discovery project by depending on their knowledge and expertise in modern organic chemistry, biology of the disease, invitro and in vivo pharmacological screening, and pharmacokinetic characteristics, with the goal of maximizing efficacy while minimizing size. Medicinal chemistry helps in discovering the drug through the process of selection and synthesis of compounds that establish structure–activity relationships and achieve efficacy and safety in preclinical animal testing.

Track 27: Biological machines

Biological machines are also known as molecular machines which are defined as the molecular component that produces quasi-mechanical movements (output) in response to specific stimuli (input). In cellular biology, macromolecular machine regularly executes tasks crucial for life, such DNA replication and ATP synthesis. In general, molecular machines can be divided into two wide categories. I)artificial and biological. Artificial molecular machines represent the molecules that are artificially designed and synthesized whereas biological molecular machines ae usually found in nature and have advanced into them after abiogenesis on earth

Track 28: Transformers for future medicinal chemists

Chemical reactions can be assembled into classes, but defining what class a specific reaction belongs to is not insignificant on a large-scale. A new study demonstrates data-driven automatic classification of chemical reactions with methods borrowed from linguistic communication processing. A chemical reaction is a process in which reactants are transformed into one or more products.

Market Analysis

Market Analysis and Insights of Medicinal Chemistry for Drug Discovery Market

Rising outline of new drugs in the market and the consumption of the same by the patrons are creating profitable medical chemistry for drug discovery market growth opportunities. Data Bridge Market Research evaluates that the medical chemistry for drug discovery market will witness a CAGR of 8.42% for the estimate period of 2021-2028.

This medical chemistry for drug discovery market report carries particulars of new current developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in rapports of emerging revenue pockets, fluctuations in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological novelties in the market. To gain more data on medical chemistry for drug discovery market contact Data Bridge Market Research for an Analyst Brief.

Global Medicinal Chemistry for drug discovery market scope and market size

According to the description, the global drug discovery services market was valued at around USD 9.3 billion in 2018 and is expected to create around $20.29 billion by 2025, at a CAGR of around 11.9% between 2019 and 2025. The process of drug discovery is used to design and/or discover new medications

The global Medicinal Chemistry 2020 is segmented on the source of type, drug type and therapeutic area. Depending upon the type, the market is segmented as biology services, medicinal chemistry and drug metabolism and pharmacokinetics. On the foundation of the drug type the segment is classified as biologics and small molecules. Similarly, on the origin of therapeutic area the segment is divided into cardiovascular diseases, oncology, neurology, diabetes, respiratory diseases and others.

Chemistry volumes continue to increase in the U.S. and chemical market expected to contract this year—As a consequence, chemical industry capital spending in the U.S. surged 12.1% in 2014 and gained 21.0% in 2015, achieving $43.58 billion and accounting for more than one-half of total edifice spending by the manufacturing sector. The association representing US based chemical manufacturers said that US chemical production (excluding pharmaceuticals) is predicted to understand the overall growth of 1.6% in 2016, followed by 4.1% growth next year, and 5.0% in 2018. Average annual gains of over 8% per year in U.S.

Chemical industry capital spending is esteemed through 2018 with only a minor slowdown in subsequent growth expected. By 2021, ACC accepts capital spending to reach $70 billion, contribute to four successive years of job growth in the industry. American chemistry revenues will surpass $1.0 trillion by 2020.

Chemistry Council specified that more than 275 new chemical production projects had been publicized since 2010 with a total value of more than $170 billion, with a full 49% already complete or under construction; 61% of these are the foreign direct investment. By 2021, U.S. capital spending by the chemical industry will reach $65 billion—more than triple the level of spending at the start of this prolonged cycle in 2010. The trade surplus in chemicals (excluding pharmaceuticals) will grow to $36 billion this year as exports rise by 2% to $132 billion and imports hold steady at $96 billion and its foreign partners will reach $227 billion this year and will grow steadily over the coming years.

Excipients in Medicinal Chemistry:

• The global excipients market is expected to grow from USD 6.17 Billion in 2017 to USD 9.78 Billion by 2025, at a CAGR of 5.93% during the forecast period from 2018- 2025

• The global chemistry excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%.

• The global chemistry is expected to reach USD 9.04 Billion by 2024 from USD 5.71 Billion in 2016 at CAGR of 5.92% (Detailed analysis of the market CAGR is provided in the report).

Top ten biggest pharma companies in the world in 2021:

Roche $49.5
Novartis $48.6.
Abbvie $45.8.
Johnson &Johnson $45.6.
Merck $43.
Pfizer $41.9.
Bristol Myers Squibb $41.3.
Sanofi $30.6.
Takeda $29.2
Amgen $25.4

Top Medicinal Chemistry Universities :

Massachusetts Institute of Technology ,United States
Harvard University, United States
University of Cambridge, United Kingdom
Stanford University, United States
University of California, Berkeley (UCB) United States
University of Oxford , United Kingdom
ETH Zurich - Swiss Federal Institute of Technology, Switzerland
California Institute of Technology (Caltech), United States
EPFL, Switzerland
Nanyang Technological University, Singapore (NTU) Singapore
The University of Tokyo, Japan
Imperial College London United Kingdom
Peking University China (Mainland)

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.
Abstracts will be compiled and conference books are made available to participants at the conference.
Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have a 45-minute time slot, the workshop/ special session will have a 60-minute time slot and the symposium will have a 60-minute time slot followed by a 5-minute Q&A session.
Graduate & Masters’ students are eligible to submit their abstracts under the poster and e-poster presentation category.
PhD students are eligible to submit their abstract under the special YRF (young researcher’s forum), poster and e-poster presentation category. NOTE: YRF category includes short oral presentations, especially for Ph. D. students
Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Participation / presentation option

Participation / presentation option

Oral presentation: Oral Presentations may include the topics from researches, theoretical, professional or private practices in a concise manner. Individuals with personal experience are also welcome to present personal experiences or narratives which help others in everyday life. Speakers with a 30-minute slot should plan to speak for 20-25 minutes, and Keynote speakers should plan to speak for 40-45 minutes, with the remaining time to be used for questions and discussion by the Session Chair.

Workshop: For workshop presenters also, the topic of the talk will be the same as an Oral presentation with more specialized techniques and detailed demonstration. The generalized time duration for a workshop presentation is about 45-50 minutes. Interested participants can join with their respective team and present the workshop with their research coordinators with special group waivers on registration.

Poster presentation: Student Poster Competition will be organized at the Euro MedChem and CADD 2024 conference is to encourage students and recent graduates to present their original research. Presenters will be given about 5-7 minutes to present the poster including questions and answers. Judges may ask questions during the evaluation of the presentation. This is an opportunity for young scientists to learn about the recent findings of their peers to increase their capacity as multidisciplinary researchers. Poster displays will be in hard copy format of 1x1 M long.

For more details regarding Poster Presentation and Judging Criteria view Poster Presentation Guidelines.

Webinar: The webinar presentation is designed for those interested attendees who cannot join in person due to schedule conflicts or other obligations. In this option, the presenter may record the presentation and their presentation will be presented in the Webinar presentation session.

E-Poster: e-Poster is also similar to the webinar presentation. In this session, their presentation will be published in the form of a poster in the conference website and the presenter abstract will be published in the conference souvenir and journal with DOI.

Exhibition: Euro MedChem and CADD 2024 has the opportunity to exhibit the products and services from commercial and non-commercial organizations like Drug manufacturers, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

To know more about exhibitor booth details and benefits visit WHY TO EXHIBIT WITH US?

Send your queries to contact@primecongress.com

Advertisement: The conference program is a valuable resource that all attendees refer again and again as they navigate the conference. Advertising in the conference program is a great way to market and can help you secure long term business.

Send your proposal to contact@europeconferences.net to know the available advertisement options and prices

contact@europeconferences.net

Premium Sponsorship package

Additional Sponsorship package

WhatsApp on (+44-1520330005) to know more about the sponsorship packages.

Visa Application

Euro MedChem and CADD 2024 organizing committee hereby reiterates that we are NOT authorized to assist with any Visa application works. You may be required to submit a Letter of Invitation, Letter of Abstract Acceptance and Registration Payment Receipt to the embassy.
Letter of Invitation: A Letter of Invitation is proof that your paper submission and registration application are accepted by the conference committee board. It will be stated in English and may help with your visa application.
Token Amount: Token amount of USD 200 can be paid and a payment receipt can be proof of payment and may help with your VISA application.
**SHOULD YOUR APPLICATION BE DENIED, THE EUROMEDCHEMAND CADD 2024 ORGANIZING COMMITTEE CAN NOT CHANGE THE DECISION OF THE MINISTRY OF FOREIGN AFFAIRS, NOR WILL WE ENGAGE IN DISCUSSION OR CORRESPONDENCE WITH THE MOFA OR THE EMBASSY ON BEHALF OF THE APPLICANT. THE REGISTRATION FEE WILL BE REFUNDED WHEN THE VISA APPLICATION OF THE INDIVIDUAL IS DENIED AND SHOULD SUBMIT VISA REJECTION PROOF**

To Collaborate Scientific Professionals around the World

Conference Date September 18-19, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Euro MedChem and CADD 2023 Conference

Supported By

Journal of Drug Metabolism & Toxicology Clinical & Medical Biochemistry Medicinal Chemistry

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Medicinal Chemistry and Computer Aided Drug Design

September 18-19, 2024 Amsterdam, Netherlands

Innovations in Medicinal Chemistry and Computational Drug Discovery: Advancing Healthcare for a Sustainable Future

Conference Series Conferences gaining more Readers and Visitors